Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySun, 02 Jun 2024 06:39:41 +0200Tue, 26 Mar 2024 17:12:00 +0100Human medicines European public assessment report (EPAR): Jcovden (previously COVID-19 Vaccine Janssen), COVID-19 vaccine (Ad26.COV2-S [recombinant]), Date of authorisation: 11/03/2021, Revision: 31, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/jcovden-previously-covid-19-vaccine-janssenHuman medicines European public assessment report (EPAR): Jcovden (previously COVID-19 Vaccine Janssen), COVID-19 vaccine (Ad26.COV2-S [recombinant]), Date of authorisation: 11/03/2021, Revision: 31, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/jcovden-previously-covid-19-vaccine-janssenTue, 26 Mar 2024 17:12:00 +0100Human medicineJcovden (previously COVID-19 Vaccine Janssen) : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5737-en_1.pdfJcovden (previously COVID-19 Vaccine Janssen) : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5737-en_1.pdfTue, 26 Mar 2024 17:10:00 +0100Human medicine